Protocol can be used in children and pregnant women ...

South African researchers publish trial results in world's leading medical journal South African and American researchers have published the results of a clinical trial in the New England Journal of ...

FDA cleared generic rifapentine for active pulmonary TB (≥12 years) with susceptible isolates, requiring combination therapy with other active antitubercular agents. Authorization also covers LTBI (≥2 ...

Treatment of latent tuberculosis is set to transform after a pair of studies from the Research-Institute of the McGill University Health Centre (RI-MUHC) revealed that a shorter treatment was safer ...

A new article published in Nature offers a promising path toward a shorter, more effective treatment for tuberculosis (TB), a bacterial disease that affects millions worldwide. Veronique Dartois, Ph.D ...

Background: Tuberculosis (TB) is a major contributor to the global burden of disease and has received considerable attention in recent years, particularly in low- and middle-income countries where it ...

When you have a contagious disease like tuberculosis (TB), refusing treatment and refusing to isolate are not personal choices. Such choices affect not only you but also everyone around you, at least ...

Kenya, Malawi and Zambia have begun preparing for the possible introduction of new tuberculosis vaccines, with health officials and partners meeting in Nairobi to plan for future deployment. The move ...

The novel antibiotic candidate sorfequiline has the potential to shorten and improve tuberculosis (TB) treatment when combined with pretomanid and linezolid (SPaL), according to new clinical trial ...

More than half of Nunavik's communities are struggling with a tuberculosis outbreak. The total number of cases in the region ...